An Open-Label Study to Evaluate Pharmacokinetic Profile of Agile TCDS AG200-15 and to Compare Exposure to Ethinyl Estradiol to Oral Contraceptive (Orthocyclen®) in Healthy Female Volunteers.

Trial Profile

An Open-Label Study to Evaluate Pharmacokinetic Profile of Agile TCDS AG200-15 and to Compare Exposure to Ethinyl Estradiol to Oral Contraceptive (Orthocyclen®) in Healthy Female Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Nov 2011

At a glance

  • Drugs Ethinylestradiol/levonorgestrel; Ethinylestradiol/norgestimate
  • Indications Pregnancy
  • Focus Pharmacokinetics
  • Most Recent Events

    • 29 Nov 2011 Results published in Contraception.
    • 02 May 2011 Results presented at the 59th Annual Clinical Meeting of American College of Obstetricians and Gynecologists.
    • 28 Nov 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top